VPC

Vestal Point Capital Portfolio holdings

AUM $1.4B

AUM

$1.4B

AUM Growth

-$286M (-17%)

Cap. Flow

+$452M

Cap. Flow % of AUM

32.26%

Top 10 Holdings %Top 10 Hldgs %

51.45%

Holding

86

New

13

Increased

27

Reduced

13

Closed

23

Top Buys

1	Arcellx ACLX	$125M
2	Crinetics Pharmaceuticals CRNX	$50.3M
3	Scholar Rock SRRK	$41.8M
4	Vera Therapeutics VERA	$34.2M
5	Nuvalent NUVL	$33.7M

Top Sells

1	Ascendis Pharma ASND	$57.6M
2	Ultragenyx Pharmaceutical RARE	$36.2M
3	VRNA Verona Pharma VRNA	$14.4M
4	Globus Medical GMED	$9.15M
5	Liquidia Corp LQDA	$7.86M

Sector Composition

1

Healthcare

100%

#	Name	Market Value	Portfolio Weight	Shares or Principal	Shares Change %	Capital Flow
76	76 Intellia Therapeutics NTLA $772M	$0	0%	0 -525,000	Closed	–
77	77 Regeneron Pharmaceuticals REGN $65.4B	$0	0%	0 -20,000	Closed	–
78	78 Roivant Sciences ROIV $7.81B	$0	0%	0 -1,250,000	Closed	–
79	79 Soleno Therapeutics SLNO $3.72B	$0	0%	0 -1,060,000	Closed	–
80	80 Sanofi SNY $127B	$0	0%	0 -750,000	Closed	–
81	81 Transmedics TMDX $4.17B	$0	0%	0 -50,000	Closed	–
82	82 Verve Therapeutics VERV $390M	$0	0%	0 -645,000	Closed	–
83	83 Zai Lab ZLAB $3.56B	$0	0%	0 -300,000	Closed	–
84	CMRX 84 DELISTED Chimerix, Inc. CMRX	$0	0%	0 -1,400,000	Closed	–
85	ACHL 85 DELISTED Achilles Therapeutics plc American Depositary Shares ACHL	$0	0%	0 -1,500,000	Closed	–
86	86 Agilent Technologies A $31.3B	$0	0%	0 -75,000	Closed	–